V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003195 | 210006587 | 1.62 | 56.7 | Adjuvant (A) | 2017-10-31 | 2017-11-14 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 101518937 |
| 210003196 | 210006588 | 1.6 | 81.2 | Adjuvant (A) | null | 2016-09-08 | FEC 60 or 75 | N | N | FEC | 100632279 |
| 210003199 | 210006590 | null | 71.8 | null | 2017-03-09 | 2017-03-24 | FEC + DOCETAXEL | 02 | null | FEC + DOCETAXEL | 100272287 |
| 210003203 | 210006593 | 0 | null | Neo-adjuvant (N) | null | 2019-11-09 | Carboplatin + Paclitaxel (weekly) | null | N | LETROZOLE + PALBOCICLIB | 101584040 |
| 210003205 | 210006595 | 1.52 | 68 | Neo-adjuvant (N) | null | 2020-08-17 | Carboplatin + Paclitaxel (3 weekly) | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101009592 |
| 210003207 | 210006596 | null | null | null | 2017-10-16 | 2017-11-01 | Trial Unspecified | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + TRASTUZUMAB | 101081006 |
| 210003209 | 210006597 | 1.67 | 56 | null | 2019-10-27 | 2019-11-08 | ABEMACICLIB + FULVESTRANT | N | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101497595 |
| 210003211 | 210006598 | 1.77 | 80 | Adjuvant (A) | null | 2018-06-10 | FEC + DOCETAXEL | N | N | FEC + DOCETAXEL | 101542306 |
| 210003213 | 210006599 | null | null | null | null | 2020-10-08 | null | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101567210 |
| 210003217 | 210006602 | 1.71 | 76 | Adjuvant (A) | 2015-08-03 | 2016-12-04 | FEC + DOCETAXEL | null | N | GEMCITABINE + NAB-PACLITAXEL | 100329896 |
| 210003218 | 210006603 | 1.6 | 49.6 | Adjuvant (A) | 2018-01-03 | 2018-01-17 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101162900 |
| 210003219 | 210006604 | 1.73 | 97.9 | Neo-adjuvant (N) | 2017-04-04 | 2017-04-24 | FEC | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101635608 |
| 210003220 | 210006605 | 1.7 | 91.4 | null | null | 2017-09-15 | EC | 02 | null | EC | 100029122 |
| 210003221 | 210006606 | null | null | null | 2017-01-16 | 2017-01-28 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100633312 |
| 210003222 | 210006607 | null | null | null | null | 2021-08-25 | FEC 60 OR 75 + DOCETAXEL | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100507774 |
| 210003226 | 210006611 | 1.65 | 69.7 | Palliative (P) | 2018-05-12 | 2018-11-10 | EC | 02 | N | EC | 100456723 |
| 210003232 | 210006614 | null | null | null | 2018-06-19 | 2018-07-11 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | EPIRUBICIN | 100731432 |
| 210003240 | 210006618 | null | 75.55 | null | 2019-03-21 | 2019-03-21 | Cyclophosphamide + Docetaxel | N | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101309644 |
| 210003246 | 210006622 | 1.57 | 0 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-22 | FEC + DOCETAXEL | null | Y | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101585242 |
| 210003251 | 210006625 | 1.57 | 83.6 | Curative (C) | 2016-10-10 | 2016-10-10 | FEC 100 | N | N | FEC | 101552911 |
| 210003255 | 210006627 | 1.56 | 70.3 | Adjuvant (A) | 2019-11-03 | 2019-11-06 | CYCLOPHOSPHAMIDE | 2 | N | CAPECITABINE | 100807375 |
| 210003256 | 210006628 | 1.63 | 80.5 | Palliative (P) | 2018-10-14 | 2018-11-03 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100634072 |
| 210003257 | 210006629 | null | 48 | Palliative (P) | 2019-04-22 | 2019-05-09 | Palbociclib | null | N | CAPECITABINE | 101116878 |
| 210003260 | 210006630 | null | null | null | 2017-02-05 | 2017-02-12 | FEC + DOCETAXEL | 02 | null | FEC + DOCETAXEL | 101642636 |
| 210003261 | 210006631 | null | null | null | 2018-08-23 | 2018-08-30 | NAB PACLITAXEL | 02 | null | EPIRUBICIN | 100518616 |
| 210003263 | 210006632 | 1.7 | 51.6 | null | 2017-06-16 | 2018-09-22 | TRASTUZUMAB EMTANSINE | null | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101824256 |
| 210003264 | 210006633 | 1.63 | 129 | null | 2019-01-17 | 2019-01-20 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100468383 |
| 210003267 | 210006634 | null | 71 | Neo-adjuvant (N) | 2015-12-13 | 2016-02-14 | Paclitaxel+Trastuzumab wkly Maint | 01 | N | PACLITAXEL + TRASTUZUMAB | 101869252 |
| 210003268 | 210006635 | 1.63 | 77 | Palliative (P) | 2018-02-20 | 2018-03-13 | null | null | N | CAPECITABINE | 100886552 |
| 210003270 | 210006637 | 1.6 | 82.7 | Palliative (P) | 2016-06-18 | 2016-06-24 | FEC + DOCETAXEL | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100006670 |
| 210003271 | 210006638 | null | null | null | null | 2016-09-11 | Epirubicin | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100350490 |
| 210003272 | 210006639 | 1.59 | 63.75 | Adjuvant (A) | 2018-12-25 | 2019-01-09 | Carboplatin + Docetaxel | 01 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100715663 |
| 210003273 | 210006640 | 1.58 | 58.4 | Adjuvant (A) | 2019-05-13 | 2019-05-27 | null | N | N | CAPECITABINE | 101807706 |
| 210003274 | 210006641 | 1.73 | 66.7 | Palliative (P) | 2018-09-18 | 2018-10-05 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101669803 |
| 210003275 | 210006642 | null | 104 | null | 2018-04-11 | 2018-07-10 | null | null | null | EPIRUBICIN | 101657148 |
| 210003277 | 210006643 | null | 72 | null | 2017-09-04 | 2017-12-09 | TCH (21 day Trastuzumab) Maint | 02 | null | CAPECITABINE | 100163578 |
| 210003278 | 210006644 | 1.62 | 71.5 | Palliative (P) | null | 2018-07-21 | FEC 100 | N | N | FEC | 100603073 |
| 210003280 | 210006645 | 1.57 | 84.7 | null | 2018-08-16 | 2018-09-01 | EC | N | null | EC | 101310569 |
| 210003282 | 210006647 | 1.63 | 72 | null | 2018-03-19 | 2018-04-03 | ABEMACICLIB + FULVESTRANT | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100093197 |
| 210003283 | 210006648 | 1.59 | 83.3 | Adjuvant (A) | 2019-01-12 | 2019-01-13 | FEC 100 | null | N | FEC | 101017890 |
| 210003284 | 210006649 | null | null | null | 2015-11-03 | 2016-02-09 | EC | 02 | null | EC | 101831786 |
| 210003287 | 210006650 | 1.56 | 64.7 | Adjuvant (A) | null | 2018-07-25 | FEC 60 or 75 | N | N | FEC | 100051775 |
| 210003289 | 210006651 | null | 79.6 | null | 2017-06-14 | 2017-06-29 | FEC + DOCETAXEL | N | null | FEC + DOCETAXEL | 101222992 |
| 210003293 | 210006654 | 1.47 | 71.5 | Neo-adjuvant (N) | 2017-10-16 | 2017-10-28 | FEC | N | N | FEC | 101260674 |
| 210003296 | 210006656 | null | null | null | null | 2019-06-20 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100768044 |
| 210003298 | 210006658 | null | 66.3 | null | null | 2020-02-22 | FEC 100 | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100231330 |
| 210003299 | 210006659 | 1.67 | 62.6 | null | 2016-10-26 | 2016-10-26 | Trial Unspecified | null | null | EPIRUBICIN | 101705452 |
| 210003300 | 210006660 | 1.55 | 61.8 | Palliative (P) | null | 2017-09-02 | FEC + DOCETAXEL | N | N | FEC + DOCETAXEL | 100201936 |
| 210003302 | 210006662 | 1.66 | 60 | Palliative (P) | null | 2019-09-11 | FEC | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100588109 |
| 210003303 | 210006663 | null | null | null | 2018-12-30 | 2019-01-09 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100312497 |